Your SlideShare is downloading. ×
Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Business Opportunities
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Spain Molecular Diagnostics Market: Innovative Technologies and Emerging Business Opportunities

84
views

Published on


0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
84
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
0
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Spain Molecular Diagnostics Market: Innovative Technologiesand Emerging Business OpportunitiesReport Details:Published:December 2012No. of Pages: 860Price: Single User License – US$5900This report comprehensive analysis of the Japanese molecular diagnostics market,including:•Major issues pertaining to the Japanese molecular diagnostics laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years.•An extensive review of DNA probe and biochip technologies, test formats, detection methodologies, trends in testing automation and amplification methods.Ten-year test volume and reagent sales forecasts for the following categories:Infectious Diseases - Genetic Diseases - Cancer - Paternity Testing/HLA TypingForensic Testing•Review of testing methodologies an instrumentation technologies.•Feature comparison of automated and semiautomated analyzers.•Sales and market shares of leading suppliers.•Over 60 specific opportunities for molecular diagnostic instruments, test systems, IT and auxiliary products.•Profiles of major suppliers, and emerging market entrants, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.•Alternative market penetration strategies.•Potential market entry barriers and risks.•Business planning issues and concerns.Get your copy of this report @http://www.reportsnreports.com/reports/211043-spain-molecular-diagnostics-market-innovative-technologies-and-emerging-business-opportunities.htmlMajor points covered in Table of Contents of this report includeTable of contents
  • 2. IntroductionWorldwide Market And Technology OverviewA. DNA Sequencing1. Introduction2. Sequencing Methods3. Autoradiography4. The Human Genome Project5. Sequencing Automation6. Image Scanners7. Fluorescent Detection8. Gene Profiling9. Gene Expression10. Polymorphism Screening11. Protein Interaction NetworksB. DNA And RNA Probe Technology1. Basic Principles2. Probe Preparation3. The DNA Probe Testa. Sample Preparationb. Hybridizationc. Separationd. Detection/Measurement4. Test Formatsa. Filter Hybridizationb. Southern Blotc. Northern Blotd. In Situ Hybridizatione. Others5. Labeling Techniques6. Amplification MethodsPolymerase Chain ReactionTemperature CyclersPCR VariationsImmuno-PCRQC-PCRDAP-PCRStrand Displacement ActivationTMALigase Chain ReactionBranched DNAHybridization Protection AssayNucleic-Acid Sequence-Based Amplification
  • 3. Self-Sustained Sequence ReplicaseOthersAmpliprobeCARCASCPTDendritic Polymer TechnologyISO-CRLATProbe NetworksRAMPRepair Chain ReactionRolling CirclesSequence Independent Gene AmplificationSequence Initiation ReactionSISPASolid Phase AmplificationC. Detection Technologies1. Radioactive Methodsa. Overviewb. Major IsotopesP-32S-35H-3I-1252. Non-Isotopic Methodsa. Enzymatic Labelsb. Chemical LabelingIndirect Chemical LabelingDirect Chemical Labelingc. Fluorescenced. Chemiluminescencee. Electrical ConductivityD. Instrumentation Review1. Abbott LCx2. Beckman Coulter/Biomek FK3. Becton Dickinson SDA4. Bio-Rad GeneScope5. Gen-Probe Tigris6. Roche Cobas Amplicor7. Tecan LS Series
  • 4. E. Biochips: Genosensors, Microarrays, and Labs-on-the-ChipLiquid Transportation and MixingSeparationReactionDetectionF. PharmacogenomicsG. Major Applications1. Microbiology/Infectious Diseasesa. Overviewb. Major Infectious DiseasesAIDSStructure and CompositionClassificationAIDS OriginsAnimal Lentivirus SystemsVirus ReceptorsHIV Infections in HumansPathogenesis and PathologyCD4T Lymphocytes and Memory CellsMonocytes and MacrophagesLymphoid OrgansNeural CellsViral CoinfectionsClinical FindingsPlasma Viral LoadPediatric AIDSNeurologic DiseaseOpportunistic InfectionsCancerImmunityVirus IsolationSerologyViral Nucleic Acid/Antigen DetectionEpidemiologyWorldwide Spread of AIDSUnited StatesRoutes of TransmissionDNA ProbesOverviewQuantitative PCRIn Situ PCRNeeded Improvements
  • 5. Viral Load/Drug Resistance TestingGenotype and Phenotype TestingBlood Banking ConsiderationsAdenovirusBackgroundDiagnostic TestsVaccines and DrugsAdeno-Associated Viruses (AAV)Anthrax/Bacillus AnthracisBackgroundDiagnostic TestsVaccines and DrugsBabesiosisBackgroundBEA and Other Bartonella DiseasesBackgroundDiagnostic TestsVaccines and DrugsChagas DiseaseBackgroundCampylobacterBackgroundDiagnostic TestsCulture IdentificationVaccines and DrugsChlamydiaBackgroundChlamydia psittaciChlmaydia pneumoniaeChlamydia trachomatisDiagnostic TestsVaccines and DrugsCreutzfeldt-Jakob’s DiseaseBackgroundBlood TransmissionDiagnostic TestsMajor Commercial and Academic PlayersBayerDisease Sciences/Bio Tec GlobalImperial College School of MedicineOrtho-Clinical DiagnosticsPall
  • 6. ProMetic Life SciencesProteome Sciences/IdexxQ-One BiotechSeronoU.S. Agricultural Research ServiceDrugsVaccinesCytomegalovirusBackgroundChorioretinitisGastrointestinalCentral Nervous System DiseaseDiagnostic TestsVaccines and DrugsEbola VirusBackgroundEpidemiologyClinical SyndromesDiagnostic TestsVaccines and DrugsEchoVirusBackgroundAcute Aseptic MeningitisisEncephalitisExanthemsRespiratory DiseaseMyopericarditisNeonatal InfectionsDiagnostic TestsVaccines and DrugsEncephalitisBackgroundDiagnostic TestsVaccines and DrugsEnterovirusesBackgroundDiagnostic TestsViral Isolation and IdentificationAntibody TestsVaccines and DrugsEpstein-Barr VirusBackground
  • 7. Diagnostic TestsVaccines and DrugsGonorrheaBackgroundDiagnostic TestsVaccines and DrugsHepatitisHepatitis AHepatitis BStructure and CompositionReplicationHepatitis CHepatitis D (Delta)Hepatitis EHepatitis GHepatitis Infections PathologyClinical FindingsLaboratory TestsHepatitis AHepatitis BHepatitis CHepatitis DHepatitis EVirus-Host Immune ReactionsEpidemiologyHepatitis AHepatitis BHepatitis CHepatitis D (Delta)Vaccines and DrugsHerpes Simplex VirusBackgroundDiagnostic TestsVaccines and DrugsLegionellaBackgroundDiagnostic TestsVaccines and DrugsLyme DiseaseBackgroundClinical DescriptionClinical Case Definition
  • 8. Laboratory Criteria for DiagnosisCase ClassificationDiagnostic TestsVaccines and DrugsMalariaMycoplasmaBackgroundUreaplasma Urealyticum & MycoplasmaHominisDiagnostic TestsVaccines and DrugsPapillomaviruses/HPVBackgroundHPV in CancerCervical NeoplasmDiagnostic TestsVaccines and DrugsPreventionParvovirus B19BackgroundMicrobiologyEpidemiologyClinical SyndromesErythema Infectiosum (Slapped Cheek)Adult PolyarthropathyTransient Aplastic CrisisTransient PancytopeniaRed Cell Aplasia in ImmunocompromisedPerinatal InfectionsDiagnostic TestVaccines and DrugsPneumoniaBackgroundDiagnostic TestsVaccines and DrugsPolyomavirusesBackgroundDiagnostic TestsVaccines and DrugsSalmonellosisBackgroundDiagnostic Tests
  • 9. Vaccines and DrugsShigellosisBackgroundDiagnostic TestsVaccines and DrugsStreptococciBackgroundDiagnostic TestsVaccines and DrugsGroup A StreptococciGroup B StreptococciToxoplasmosisBackgroundDiagnostic TestsVaccines and DrugsTuberculosisBackgroundDiagnostic TestsMicroscopic CharacteristicsCultural CharacteristicsSkin TestsMDRTBVaccines and DrugsWest Nile VirusBackgroundClinical SyndromesDiagnostic TestsVaccines and DrugsYersiniaBackgroundDiagnostic TestsVaccines and Drugsc. Antibiotic Susceptibility2. Cancer Testinga. Overviewb. Major Cancer TypesProstateLungColon and RectumBreastSkinUterine
  • 10. LeukemiaOralc. OncogenesO Abl/abl-bcrAIB1BCL-2BRCA1CD44C-fosC-mybC-mycCYP17Erb-BHPC1N-mycP40P51P53PIK3CAPTI-1RasRegSisSrc3. Genetic Diseasesa. Overviewb. Nucleic Acid Amplificationc. Chromosome Imagingd. Genomics Technologiese. Proteomics Technologiesf. Current Pharmacogenomic Testsg. Future Pharmacogenomic Testingh. Major DiseasesAchondroplasiaAutosomal Dominant Polycystic KidneyDiseaseCancerCosmetogenomicsCystic FibrosisDowns SyndromeDuchenne and Becker Muscular DystrophyFactor V (Leiden)
  • 11. Factor IX DeficiencyFragile X SyndromeHeart DiseaseHemochomatosisHemophiliaHuntingtons DiseaseMaternal-Fetal IncompatibilityMultiple Endocrine NeoplasiaPhenylketonuria (PKU)Polycystic Kidney Disease (PKD)Prenatal ScreeningRetinitis PigmentosaRetinoblastomaSickle Cell AnemiaSpinal Muscular AtrophyVitamin B12 Metabolismi. Social Issues and Concerns4. Forensic Testinga. Overviewb. Multilocus and Single Locus ProbesMultilocus ProbesSingle Locus ProbesPCR and RFLPc. The FBId. DNA Profile Data BanksU.S.A.U.K.e. Judicial Implementationf. Major Crime Categoriesg. Factors Contributing to the DNA ProbeMarket ExpansionTechnology AvailabilityUse of Hair as Evidenceh. Wildlife Forensics5. Paternity Testing/HLA Typing6. Other Applicationsa. Disease Susceptibility Testingb. Cardiovascular Diseasesc. Diabetesd. Alzheimers Diseasee. Periodontal Diseasef. Plasma Purification
  • 12. g. Organ Transplantationh. Water Contaminationi. OtherH. Competing/complementing Technologies1. Monoclonal Antibodies/Immunoassays2. RNA Probes3. Two-Dimensional Electrophoresis4. Flow CytometrySpainA. Executive SummaryB. Business EnvironmentC. Market StructureD. Market Size, Growth And Major Suppliers’Sales And Market SharesMajor Product Development OpportunitiesA. InstrumentationB. Reagent Kits and Test Systems/panelsC. Computers, Software and AutomationD. Auxiliary ProductsDesign Criteria For Decentralized Testing ProductsAlternative Market Penetration StrategiesA. Internal DevelopmentB. Collaborative ArrangementsC. University ContractsD. Distribution Strategies For Decentralized Testing Markets1. Marketing Approaches2. Product Complexity3. Customer Preference4. Established Suppliers5. Emerging Suppliers6. Major Types Of Distributors7. Market SegmentationPotential Market Entry Barriers And RisksA. Market MaturityB. Cost ContainmentC. CompetitionD. Technological Edge And LimitationsE. Patent ProtectionF. Regulatory ConstraintsG. Decentralized Testing Market ChallengesCompetitive ProfilesAbbott
  • 13. AffymetrixAgilentApplied Gene TechnologiesArcaBeckman Coulter/DanaherBecton DickinsonBiokitBioMerieuxBio-RadBiotestCaliperCepheidDecodeDiadexusEikenEnzoExact SciencesFujirebioGen-ProbeHologicIlluminaInnogenetics/SolvayKreatechLi-Cor BiosciencesLife TechnologiesMonogram BiosciencesMyriad GeneticsNanogen/ElitechNovartisOrchid CellMarkOrtho-Clinical DiagnosticsProteome SciencesQiagenRocheScienionSequenomShimadzuSiemensSierra MolecularTakara BioTecan GroupAppendix I: Major Universities and Research Centers
  • 14. Developing Molecular Diagnostic TechnologyAppendix II: Glossary of TermsAppendix III: Currency Exchange RatesList of TablesMajor Companies Developing or Marketing AIDS MolecularDiagnostic And Other Direct Identification TestsMajor Companies Developing or Marketing AdenovirusMolecular Diagnostic And Other Direct Identification TestsMajor Companies Developing or Marketing CampylobacterMolecular Diagnostic And Other Direct Identification TestsMajor Companies Developing or Marketing Chlamydia Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing CMV Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing EBV Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Gonorrhea Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Hepatitis Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Herpes Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Legionella Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Lyme Disease Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Mycoplasma Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Papilloma Virus Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Pneumonia Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Salmonella Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Shigella Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Streptococci Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Toxoplasmosis Molecular Diagnostic And Other DirectIdentification TestsMajor Companies Developing or Marketing Tuberculosis Molecular Diagnostic And Other DirectIdentification Tests
  • 15. Oncogenes Potential Application in Cancer DiagnosisMajor Companies Developing or Marketing Cancer Molecular Diagnostic TestsMajor Companies Developing or Marketing Molecular Diagnostic Test For Genetic DiseasesSummary Table Spain, Molecular Diagnostic Test Volume And Sales Forecast by MajorApplicationSpain, Laboratories Performing DNA Sequencing By Market SegmentSpain, Molecular Diagnostics Market Potential Laboratory Universe by Market SegmentSpain, Molecular Diagnostic Test Volume Forecast By Major ApplicationSpain, Major Infectious Disease Molecular Diagnostics Test Volume ForecastSpain, Infectious Disease Screening NAT Volume ForecastSpain, Molecular Diagnostics Market Forecast By Major ApplicationSpain, Infectious Disease Screening NAT Reagent Market Forecast by TestSpain, Molecular Diagnostics Market By Major SupplierSpain, HIV/Hepatitis NAT Market Reagent Sales By Major SupplierContact: sales@reportsandreports.com for more information.

×